Missed the call but appreciate those that have provided comments...

Missed the call but appreciate those that have provided comments on key points and themes. Interesting to see Michael reads HC, which most small cap CEO’s do but probably don’t admit to.

Given the lack of Zoleo reporting and that it’s excluded from the 4C we are going to be a bit light on with catalysts until August when they drop the annual report.

Sure there will be the odd new sales order for Zoleo etc but until investors and micro cap funds see some details we’re going to be range bound from 25-35c IMO. As Stealth has mentioned, rest of world including Europe would be a good announcement and could lead to a mini re-rate but we need to see details and expected volumes for it to hold.

I still have this as an inflection year with a small net profit but with much larger gains from FY22 onwards.

With a lack of disclosure patience is required but I’m confident we’ll all be very well rewarded in time. Just remember the market cap is still just $20m - lots and lots of upside.